# Safety and Efficacy of Intrathecally Administered Magnesium Sulfate

> **NCT03459417** · NA · COMPLETED · sponsor: **South Egypt Cancer Institute** · enrollment: 90 (actual)

## Conditions studied

- Abdominal Cancer
- Abdominal Pain

## Interventions

- **PROCEDURE:** intrathecal morphine+LA
- **PROCEDURE:** intrathecal morphine+LA+ Mg sulp. 50
- **PROCEDURE:** intrathecal morphine+LA+ Mg sulp. 100

## Key facts

- **NCT ID:** NCT03459417
- **Lead sponsor:** South Egypt Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03459417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03459417, "Safety and Efficacy of Intrathecally Administered Magnesium Sulfate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03459417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*